208665-96-7 Usage
Uses
Used in Pharmaceutical Research:
3-Bromo-4-isobutoxybenzothioamide is utilized as a research compound for its potential anti-inflammatory and analgesic properties. It is employed in scientific studies to explore its pharmacological effects and possible therapeutic applications, with the aim of understanding its impact on inflammatory and painful conditions.
Used in Enzyme and Receptor Modulation Studies:
In the field of biochemistry, 3-Bromo-4-isobutoxybenzothioamide is used as a tool to investigate its interaction with enzymes and receptors. This helps researchers to uncover its mechanism of action and assess its potential as a lead compound for the development of new pharmaceutical drugs.
Used in Drug Development:
3-Bromo-4-isobutoxybenzothioamide is considered in the drug development process as a candidate for further research. Its pharmacological profile is being studied to determine its full potential, with ongoing research aimed at understanding its efficacy and safety for use in treating specific conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 208665-96-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,8,6,6 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 208665-96:
(8*2)+(7*0)+(6*8)+(5*6)+(4*6)+(3*5)+(2*9)+(1*6)=157
157 % 10 = 7
So 208665-96-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H14BrNOS/c1-7(2)6-14-10-4-3-8(11(13)15)5-9(10)12/h3-5,7H,6H2,1-2H3,(H2,13,15)
208665-96-7Relevant academic research and scientific papers
2 - (3-cyano-4-alkoxy) phenyl-4-substituted thiazole-5- formic acid class compound, composition and its preparation and use
-
, (2016/10/07)
The invention relates to a 2-(3-cyano-4-alkoxy) phenyl-4-substituted thiazole-5-formic acid compound which has xanthine oxidase inhibitory activity and is shown in a general formula I, a composition and preparation methods thereof. The invention also relates to applications of the compound and the composition thereof to preparation of medicaments for treating and/or preventing hyperuricemia and gout diseases. In the formula I, R2 is substituted or unsubstituted phenyl or a substituted or unsubstituted heteroaromatic radical, R1 is a substitutive aliphatic group of a straight chain or a branched chain, substituted or unsubstituted alicyclic hydrocarbonyl or substituted or unsubstituted aryl alkyl and A is an oxygen atom, a sulfur atom or a nitrogen atom.
A PROCESS FOR THE PREPARATION OF FEBUXOSTAT
-
Page/Page column 15-16, (2010/12/29)
The present invention relates to a process for the preparation of Febuxostat, useful in the pharmaceutical field for the treatment of the hyperuricemia.
